THERAPEUTIC EFFICACY OF LEVONORGESTREL INTRAUTERINE SYSTEM AS AN ALTERNATIVE TO HYSTERECTOMY FOR MANAGEMENT OF HEAVY MENSTRUAL BLEEDING IN PERIMENOPAUSAL WOMEN
Â Objective: This prospective observational study has been conducted to find out the efficacy and patient satisfaction of levonorgestrel intrauterine system (LNG-IUS), and it was compared with results of hysterectomy in perimenopausal Indian women with heavy menstrual bleeding (HMB).
Methods: It was a prospective study conducted on 135 cases after taking consent. Patients were inserted with LNG-IUS, and the outcome in terms of further bleeding and quality of life was compared to that of hysterectomy.
Results and Conclusion: Levonogestrol containing-IUS is a highly effective treatment of HMB in perimenopausal women. It is a safe, effective, and quality of life after treatment makes it a good alternative to hysterectomy for HMB.
2. Munro MG, Critchley HO, Broder MS, Fraser IS, FIGO Working Group on Menstrual Disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet 2011;113:3-13.
3. Sushil K, Antony ZK, Mohindra V, Kapur A. Therapeutic use of LNG intrauterine system (Mirena) for menorrhagia due to benign lesions-analternative to hysterectomy? J Obstet Gynecol India 2005;55:541-3.
4. Royal College of Obstetricians and Gynaecologists. National Collaborating Centre for Womenâ€™s and Childrenâ€™s Health. Heavy menstrual bleeding. London: Royal College of Obstetricians and Gynaecologists; 2007 (Guideline CG44).
5. Health Technology Assessment No. 19.88. on Behalf of the ECLIPSE Collaborative Group. Southampton (UK): NIHR Journals Library; 2015
6. David A, Grinces, Parker K, Jones. A clinical guide to LNG-IUS uses. Philadelphia: Lippincott Williams & Wilkins; 2001
7. El-Hemaidi I, Gharaibeh A, Shehata H. Menorrhagia and bleeding disorders. Curr Opin Obstet Gynecol 2007;19:513-20.
8. Irvine GA, Campbell-Brown MB, Lumsden MA, HeikkilÃ¤ A, Walker JJ, Cameron IT, et al. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. Br J Obstet Gynaecol 1998;105:592-8.
9. Tang GW, Lo SS. Levonorgestrel intrauterine device in the treatment of menorrhagia in chinese women: Efficacy versus acceptability. Contraception 1995;51:231-5.
10. Andersson JK, Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynaecol 1990;97:690-4.
11. Barrington JW, Simpkins P. The LNG-IUS for management of menorrhagia. BJOG Int J Obst Gynaecol 1997;104:614-6.
12. Fedele L, Bianchi S, Raffaelli R, Portuese A, Dorta M. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device. Fertil Steril 1997;68:426-9.
13. Crosignani PG, Vercellini P, Mosconi P, Oldani S, Cortesi I, De Giorgi O, et al. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding. Obstet Gynecol 1997;90:257-63.
14. Scholten PC, Christaens GC, Haspel AA. Treatment of menorrhagia by LNG-IUS. Clininal Performance and Impact on Menstruation. Netherlands: Uterecht University Hospital; 1989. p. 47-55.
15. Garg S, Soni A. A Non- surgical lifeline for Abnormal uterine bleeding (AUB)-the LNG IUS. Indian J Obstet Gynecol Res 2016;3:23-7.
16. Yazbeck C, Omnes S, Lavenu VM, Madelenat P. Levonorgestrel-releasing intrauterine system in the treatment of dysfunctional uterine bleeding: A French multicenter study. Gynecol Obstet Fertil 2006;34:906-13.
17. Marjoribanks J, Lethaby A, Farquhar C. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev 2016;1:CD003855.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.